Movers roundup: Bed Bath & Beyond, Vivus

Movers roundup: Bed Bath & Beyond shares fall on earnings; Vivus shares rise

Associated Press

Among the stock activity stories for Thursday, Dec. 20, from AP Business News:

— Shares of Bed Bath & Beyond Inc. fell to their lowest point in more than a year as its fiscal fourth-quarter and full-year earnings forecasts missed analysts' expectations.

— Shares of Vivus Inc. rose after the drug developer said pharmacy benefits manager Express Scripts Holding Co. has added its weight loss pill Qsymia as a standard benefit option to its national formulary.

— Accenture PLC's stock fell as the consulting firm's fiscal first-quarter revenue missed analysts' estimates, and it provided a second-quarter revenue forecast below Wall Street expectations.

View Comments (0)